|
Andrew Cosentino, a graduate of Yale University, has nearly
30 years of
experience in structuring, negotiating and consummating
strategic transactions
for public and private companies ranging from early growth
phase companies to
mature industry leaders, as well as investment banking firms
and funds, in the
United States, Europe and elsewhere. After many years as a
partner in major
U.S. law firms, Mr. Cosentino left the private practice of
law to offer his
own services as a high level consultant to businesses,
primarily consulting
for management and boards of directors of public and private
companies in high
technology, investment banking, biotechnology, and
software-driven businesses.
He regularly counsels clients in the formation and
structuring, capitalization
(through private and public equity financing, including seed
capital, early
stage, venture capital and mezzanine financing, private
placements, IPOs and
secondary offerings, and bank, lease and other financings),
operation
(including matters such as key contracts with vendors,
customers and
executives, compliance and corporate governance), merger,
acquisition and
disposition, and recapitalization and reorganization of
their businesses. As
an outgrowth of consulting relationships, Mr. Cosentino
serves as a director
of a number of publicly listed companies.
In addition to joining the Board, Joseph Zappulla has
accepted the role as
Chairman of the Audit Committee, replacing Peter Rugg, who
will be focusing
upon other matters and remains on the Board. Mr. Zappulla
has over 25 years
of executive management experience in financial operations,
investment
banking, mergers and acquisitions, investment analysis,
capital raising,
corporate development and strategic planning and budgeting.
Mr. Zappulla
founded in 1999 and serves as CEO of Grannus Financial
Advisors, Inc., a
strategic consulting firm on matters such as financial
operational review,
corporate governance, investor relations, capital raising,
mergers and
acquisitions, and general business needs. Prior to Grannus,
Mr. Zappulla
served as a director for Mabon Securities engaged to help
turn-around the 100
year brokerage firm. In this role, he also managed strategic
planning,
compliance, and internal audit. Earlier, he served as member
of the U.S.
equities management team at S.G.Warburg and Co. directing
the firm's
institutional equities effort worldwide, as well as its
finance and
administration, treasury operations, and accounting in the
U.S. For nearly 10
years, Mr. Zappulla worked at Donaldson, Lufkin and Jenrette
in its
institutional equities division in varying capacities from
trading to
management, including strategic planning and budgeting and
financial
administration. He began his career at American Express Co.
as an analyst,
where he spent two years analyzing financial operations and
markets. He holds
an MBA from Suffolk University (Boston, MA) and is currently
FINRA Registered
Series 7, 24 and 63.
Dr. Peter Gammel previously served on the Company's Board of
Directors
from August 10, 2006 to November 13th 2006. In addition to
rejoining the
Board, he will assume the added responsibility of Governance
Committee
Chairman. Dr. Gammel has his PhD in Physics from Cornell
University (1987)
and his B.S. in both physics and mathematics from M.I.T.
(1981), and was
awarded A.D. White Fellowship and the Phi Beta Kappa, W.
McMillan Prize. Dr.
Gammel has
published more than 200 technical publications, presented at
over
50 conferences and has been issued or is in the process of
applying for more
than 25 patents. He is currently Chief Technical Officer and
Vice President
of Engineering for SiGe Semiconductor. SiGe is a global
leader in RF for WLAN
and GPS Dr. Gammel was Vice President of Engineering at
Renaissance Wireless
where he managed the development of a line of RF acoustic
wave filters and
switches, and served as Chief Technical Officer of the
Analog Products
Business Unit of Agere Systems, where his team was
responsible for the
development of laterally diffused metal oxide semiconductor
power amplifiers.
For over 15 years into 2002, Dr. Gammel was a Distinguished
Member of
Technical Staff with Bell Laboratories-Lucent Technologies.
Dr. Gammel also
served as the Chief Technical Officer for Advanced Nanotech
for 14-months
through August 2006.
Jon Buttles has been a partner and consultant to the
Company's Owlstone
Nanotech, Inc. subsidiary since its inception. Mr. Buttles
is the founder and
managing partner of Core Equity Group LLC, a financial
advisory and strategic
consulting firm focused on building, financing and growing
emerging technology
companies. Prior to Core Equity Group LLC, Mr. Buttles was
managing director
at SBI USA LLC, a boutique investment bank formerly
affiliated with SOFTBANK
Japan, where he led banking transactions in the public and
private banking
sectors across a diverse group of industries. Prior to SBI
USA, Mr. Buttles
worked at Monument Advisors Inc, a middle market private
equity boutique,
managing a mezzanine fund and a leveraged buyout fund. Mr.
Buttles has a
strong base of corporate finance experience in technology
investment banking,
public and private placements, leveraged buy-outs, private
equity fund
management and mergers and acquisitions. Mr. Buttles holds a
bachelors degree
from Miami University in Finance.
"The addition of these new members to the Board of Directors
marks a
significant milestone in the progression of the company,"
commented Bret
Bader, CEO of Advance Nanotech. "The return of Dr. Peter
Gammel as a Board
member is a clear validation of the direction we are heading
as a company.
Dr. Gammel's familiarity with the Owlstone sensor,
experience in
commercialization and application development, along with
his contacts in the
industry, will prove extremely valuable to Owlstone as it
continues its
product development and pursuit of strategic relationships.
Andrew Cosentino
has been integral to the completion of the Exchange
Agreement, and his
business and securities experience will prove invaluable to
the Company as it
continues its pursuit of strategic partnerships and
development agreements."
Mr. Bader continued, "Owlstone has benefited greatly from
Jon Buttles'
assistance over the years. His understanding of our business
model, coupled
with the business expertise has enabled him to provide
knowledgeable counsel
during our transition period. His continued involvement from
a Board level
will be instrumental as we move into the commercializing
phase." Mr. Bader
concluded, "We were encouraged when Joe Zappulla accepted a
seat on the Board
and, especially, as Chairman of the Audit Committee. Joe has
spent an a great
deal of time examining our financial structure, and
understands the importance
of financial disclosure to the investment community. His
background in
strategic planning and financial modeling will also aid us
in this crucial
process. We are fortunate to have attracted such talent to
augment the
company's leadership. This will enable me to focus my
energies on developing
applications using our unique technology and building a
solid revenue stream."
About Owlstone Nanotech, Inc.
Owlstone
Nanotech, Inc. ("Owlstone") is majority owned subsidiary of
Advance Nanotech and is a pioneer in the commercialization
of
nanotechnology-based chemical detection products. The
Owlstone Detector is a
revolutionary dime-sized sensor that can be programmed to
detect a wide range
of chemical agents that may be present in extremely small
quantities. Using
leading-edge micro- and nano-fabrication techniques,
Owlstone has created a
complete chemical detection system capable of superior
performance,
significantly smaller and can be produced materially more
cost than existing
technology. There are numerous applications -- across
industries from security
and defense to industrial process, air quality control and
healthcare -- that
depend on the rapid, accurate detection and measurement of
chemical compounds.
Owlstone works
with market leaders within these applications to integrate
the
detector into next generation chemical sensing products and
solutions.
Owlstone's
technology offers a unique combination of benefits,
including:
small size, low manufacturing costs, minimal power
consumption, reduced
false-positives, and a customizable platform.
About Advance Nanotech
Advance Nanotech is in the process of shifting to becoming
an operating
company focused on chemical and biological next generation
detection. Its
proprietary technologies, developed at Cambridge University,
are uniquely
silicon based thus offering miniaturization and network
capability with
wireless opportunities. The advantages of this protocol
permits for real-time
precision analytics leading to potential prevention of
ensuing issues,
concerns and dangers. Through its majority owned subsidiary,
Owlstone
Nanotech, Advance Nanotech has 1 recently awarded patent and
18 patent pending
applications. For more information on Advance Nanotech,
please visit
www.advancenanotech.com
|
